top of page
News
We're thrilled to share the latest developments from our company.
Suche
ODI Pharma
24. Nov. 20233 Min. Lesezeit
ODI Pharma AB: Publication of interim report report Q1 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2023 – September 2023. The report is...
0 Kommentare
ODI Pharma
24. Nov. 20231 Min. Lesezeit
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
0 Kommentare
ODI Pharma
24. Nov. 20231 Min. Lesezeit
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2022/2023....
0 Kommentare
ODI Pharma
23. Nov. 20231 Min. Lesezeit
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2023/2024 and the...
0 Kommentare
ODI Pharma
13. Nov. 20235 Min. Lesezeit
Notice to Annual General Meeting in ODI Pharma AB (publ)
The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Friday, 15th of...
0 Kommentare
ODI Pharma
13. Nov. 20234 Min. Lesezeit
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma fredagen den 15 december 2023 kl. 10.30 i bolagets lokaler...
0 Kommentare
ODI Pharma
24. Aug. 20234 Min. Lesezeit
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2022 – June 2023. The report is available...
0 Kommentare
ODI Pharma
7. Aug. 20233 Min. Lesezeit
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has entered through its Polish subsidiary into a collaboration...
0 Kommentare
ODI Pharma
1. Juni 20232 Min. Lesezeit
ODI Pharma AB receives loan financing of EUR 350,000
ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has secured loan financing of EUR 350,000 from an external...
0 Kommentare
ODI Pharma
25. Mai 20233 Min. Lesezeit
ODI Pharma AB: Publication of interim report report Q3 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2022 – March 2023. The report is available...
0 Kommentare
ODI Pharma
23. Feb. 20233 Min. Lesezeit
ODI Pharma AB: Publication of half-year report 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2022. The report is available...
0 Kommentare
ODI Pharma
24. Jan. 20232 Min. Lesezeit
ODI Pharma receives approval from the Office for Registration of Medicinal Products in Poland
ODI Pharma AB (“ODI” or the “Company”) announces today that the Company has received approval from the Office for Registration of...
0 Kommentare
ODI Pharma
16. Dez. 20222 Min. Lesezeit
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
0 Kommentare
ODI Pharma
16. Dez. 20222 Min. Lesezeit
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 16 december 2022 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
0 Kommentare
ODI Pharma
25. Nov. 20223 Min. Lesezeit
ODI Pharma AB: Publication of interim report Q1 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report concerning the period July 2022 to September 2022. The report...
0 Kommentare
ODI Pharma
25. Nov. 20221 Min. Lesezeit
ODI Pharma AB publishes the annual report for the fiscal year 2021/2022
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
0 Kommentare
ODI Pharma
25. Nov. 20221 Min. Lesezeit
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2021/2022
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2021/2022....
0 Kommentare
ODI Pharma
24. Nov. 20221 Min. Lesezeit
ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2022/2023 and the...
0 Kommentare
ODI Pharma
15. Nov. 20225 Min. Lesezeit
Notice to Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
0 Kommentare
ODI Pharma
15. Nov. 20224 Min. Lesezeit
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma fredagen den 16 december 2022 kl. 10.30 i bolagets lokaler...
0 Kommentare
bottom of page